Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

China flag China · Delayed Price · Currency is CNY
106.62
-0.39 (-0.36%)
Mar 9, 2026, 3:04 PM CST
214.14%
Market Cap 16.98B
Revenue (ttm) 430.98M
Net Income (ttm) -197.25M
Shares Out 159.27M
EPS (ttm) -1.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,079,993
Average Volume 12,260,944
Open 104.76
Previous Close 107.01
Day's Range 104.11 - 107.91
52-Week Range 24.44 - 188.93
Beta 1.20
RSI 46.65
Earnings Date Apr 29, 2026

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 760
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300436
Full Company Profile

Financial Performance

In 2024, SHE:300436's revenue was 441.46 million, an increase of 4.43% compared to the previous year's 422.71 million. Losses were -156.30 million, -55.16% less than in 2023.

Financial Statements

News

There is no news available yet.